Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia. 2010

Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
Institut Pasteur de Montevideo, Montevideo, Uruguay.

B-cell chronic lymphocytic leukemia (CLL) is characterized by the accumulation of long-lived circulating clonal leukemic B-cells, although the etiopathogenesis remains unclear. The incidence of CLL is variable in different regions around the world. While it is the most frequent chronic leukemia in Western countries, it has a low incidence in Asia. In this work we have investigated the immunoglobulin heavy chain gene rearrangements and mutational status in 80 Uruguayan patients with CLL, and compared these results with those obtained in other geographic regions. Our results demonstrate that Uruguayan patients with CLL display an IGHV gene usage which resembles that observed in Mediterranean countries and exhibits certain differences compared with Brazilian and Asian series, as expected, considering the ethnic basis of the Uruguayan population. This suggests that genetic influences could be important in the development and etiopathogenesis of CLL, but larger studies are necessary to substantiate this possibility.

UI MeSH Term Description Entries
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005843 Geography The science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. (From Webster, 3d ed) Factor, Geographic,Factors, Geographic,Geographic Factor,Geographic Factors,Geography, Human,Human Geography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
November 2022, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
August 2013, Clinical lymphoma, myeloma & leukemia,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
October 2011, Leukemia & lymphoma,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
December 2009, Cancer science,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
January 2023, Frontiers in oncology,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
December 2021, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
June 2007, Leukemia,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
February 1995, Molecular and cellular biology,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
March 1990, Nucleic acids research,
Sergio Bianchi, and Pilar Moreno, and Ana Inés Landoni, and Hugo Naya, and Pablo Oppezzo, and Guillermo Dighiero, and Raúl Gabús, and Otto Pritsch
September 2018, American journal of hematology,
Copied contents to your clipboard!